Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

WIN 2019 Symposium /
Optimising patient enrolment and efficacy of precision oncology clinical trials

23rd - 24th Jun 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 10.07.19
Views: 382

Prof Apostolia-Maria Tsimberidou - The University of Texas MD Anderson Cancer Center, Houston, USA

Prof Apostolia-Maria Tsimberidou speaks to ecancer at the WIN 2019 Symposium in Paris about how clinical trials can be optimised in precision oncology.

She explains that in order to increase optimisation it is essential to have comprehensive molecular profiling for all patients.

Prof Tsimberidou states that implementing this is a challenge due to small fraction of cancer patients who are enrolled in clinical trials.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation